Patient Perspectives in Squamous Cell Carcinoma Clinical Trials
Not yet recruiting
- Conditions
- Squamous Cell Carcinoma
- Registration Number
- NCT05929547
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Clinical research participation has historically been heavily biased toward specific demographics.
This study will invite several participants to gather a wide range of information on clinical trial experiences for squamous cell carcinoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of squamous cell carcinoma.
People with squamous cell carcinoma who are invited to take part in clinical research will benefit from the analysis of the data.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Aged ≥ 18 years old
- Confirmed diagnosis of squamous cell carcinoma
- Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.
Exclusion Criteria
- Inability to provide written informed consent
- Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
- Enrolled in another research study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patients who decide to enroll in a squamous cell carcinoma clinical trial 3 months Rate of patients who remain in squamous cell carcinoma clinical trial to trial completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States